Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery

• Published in: Toxins Vol. 15; no. 3; p. 221
• Main Authors: Lee, Hsiang-Ying, Kuo, Hann-Chorng
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.03.2023; MDPI
• Subjects: Administration, Intravesical; Antigens; Bladder; Botulinum toxin; Botulinum toxin type A; Botulinum Toxins, Type A - adverse effects; Care and treatment; Development and progression; Dosage and administration; Effectiveness; Female; Health aspects; Humans; Injection; Intervention; Male; Men; Neuromuscular Agents - adverse effects; overactive bladder; Pathophysiology; Patients; Prostate; Prostate - surgery; Prostate-specific antigen; Prostatectomy; Questionnaires; Review; Sexes; Side effects; Sphincter; Surgery; Toxins; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neck Obstruction - drug therapy; Urinary Bladder Neck Obstruction - surgery; Urinary Bladder, Overactive - drug therapy; Urinary incontinence; Urination disorders; Urine; Urogenital system; Taiwan; United States > US; botulinum toxin; overactive bladder; men

Purpose: A significant proportion of men without bladder outlet obstruction (BOO) have been reported to have overactive bladders (OAB). This article aimed to review the specific group of reports on the use of botulinum toxin type A (BTX-A) injections into the bladder wall. Materials and methods: Ori...